Skip to content

Clinical trials

Completed Phase 1 Pulmonary Arterial Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 1 Status: Completed Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20093
20105
20112
20133
20152
20161
20173
201810
20197
20202
20216
20222
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bial - Portela C S.A.9
United Therapeutics7
Humanis Saglık Anonim Sirketi3
Merck Sharp & Dohme LLC3
Vigonvita Life Sciences3
Aires Pharmaceuticals, Inc.2
Altavant Sciences GmbH2
Pharmosa Biopharm Inc.2
University of Chicago2
Actelion1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension54
Hypertension, Pulmonary8
Cardiovascular Diseases2
Erectile Dysfunction2
Familial Primary Pulmonary Hypertension2
Lung Diseases2
Renal Insufficiency2
Acquired Immunodeficiency Syndrome1
Aneurysm1
Connective Tissue Diseases1

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.